Day February 3, 2026
HMN 2026: How Gut microbiota can predict long-term complications of acute pancreatitis
HMN 2026: How Gut bacteria may be linked to memory decline in mild cognitive impairment and Alzheimer’s disease
HMN 2026: How Grok created three million sexualized images
HMN 2026: How Off-grid filtration technology can remove over 99% of nanoplastics smaller than 50 nm
Schematics and performance of electrokinetic filtration platform. Credit: Materials Today (2025). DOI: 10.1016 Professor Jeong-Min Baik’s research group of the SKKU School of Advanced Materials Science and Engineering has developed a reusable electrokinetic filtration platform capable of filtering more than…
HMN 2026: How GOP cuts will cripple Medicaid enrollment, warns CEO of largest public health plan
HMN 2026: How Google offers users option to plug AI mode into their photos, email for more personalized answers
HMN 2026: Why connecting with others is good for your health
HMN 2026: How GNSS-only method delivers stable positioning for autonomous vehicles in urban areas
The proposed approach estimates position using a particle filter without integer ambiguity resolution, while a tightly coupled Kalman filter computes velocity from raw Doppler measurements. Particle-wise NLOS rejection and a Student’s t-distribution filter improve robustness in dense urban environments, enabling…
HMN 2026: What is the comprehensive overview GLP-1 medications:
With more studies emerging, GLP-1 and dual GIP/GLP-1 medications have become well-established options for those with obesity or type 2 diabetes. These treatments can positively affect appetite, metabolism and overall cardiometabolic health, offering a meaningful approach to long-term management for…
HMN 2026: How Global societies unite to address environmental threats to heart health
HMN 2026: How Global power struggles over the ocean’s finite resources call for creative diplomacy
HMN 2026: How Global network of virologists warns of measles resurgence
HMN 2026: How Global inequality in parks undercuts the ‘suburban dream,’ suggests research
Scores for nature appreciation and physical activities in London parks. Credit: Nature Cities (2025). DOI: 10.1038/s44284-025-00345-4 Huge inequality between inner-city and suburban parks across the world could be threatening well-being globally, suggests a study from King’s College London and Nokia…
HMN 2026: How Glassy dynamics model predicts lipid exchange rates across cell membranes
Credit: Fayette Reynolds M.S. from Pexels Biological processes that govern our lives are many, intertwined, and often difficult to understand. They involve countless interactions happening at once—molecules recognizing each other, signals being transmitted, and matter being transported with precise timing—making…
HMN 2026: why women are less likely to hold leadership positions in logistics
HMN 2026: How AI swarms can threaten democracy by manufacturing fake public consensus
HMN 2026: How every generation uses AI, from boomers to Gen Z
HMN 2026: How Single gene is found to influence gut bacteria balance and IBD susceptibility
HMN 2026: How Gender quotas for public company boards spur rise in women CEOs
HMN 2026: How Tear gas and pepper spray can pose serious respiratory risks
HMN 2026: How Gamified platform helps children with neurodiversity and anxiety
HMN 2026: How Being close to someone with a gambling problem may raise your own risk
HMN 2026: How future vaccine trials must include care home residents
HMN 2026: What is the hidden epidemic of workplace loneliness
HMN 2026: How Financial and peer support increase women’s reproductive agency in India
HMN 2026: How Fremanezumab reduces number of migraine days in children, teens
HMN 2026: How Market freedom may impact homicide rates
HMN 2026: How Progression-free survival is prolonged with sacituzumab govitecan plus pembrolizumab in triple-negative breast cancer
For patients with previously untreated, programmed death ligand 1 (PD-L1)-positive, locally advanced unresectable or metastatic triple-negative breast cancer (TNBC), sacituzumab govitecan plus pembrolizumab yields significantly longer progression-free survival than chemotherapy plus pembrolizumab, according to a study published in the Jan.…
